NDAINHALATIONGAS
Approved
Dec 2022
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
XENOVIEW (xenon xe 129 hyperpolarized) by Polarean Imaging is magnetic resonance contrast activity [moa]. First approved in 2022.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XENOVIEW (Xenon Xe 129 Hyperpolarized) is a hyperpolarized contrast agent administered via inhalation as a gas for magnetic resonance imaging. It enhances MRI visualization of pulmonary ventilation by leveraging hyperpolarized xenon's unique magnetic properties. The drug enables clinicians to assess regional lung function non-invasively.
Peak9.7 years to LOE
Early-stage peak-phase product with no current competitive pressure; team growth trajectory depends on healthcare system adoption of hyperpolarized MRI imaging infrastructure.
Mechanism of Action
Magnetic Resonance Contrast Activity
Pharmacologic Class:
Hyperpolarized Contrast Agent
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on XENOVIEW offers exposure to a cutting-edge imaging biotech product with green-field market potential and zero competitive noise. Roles emphasize building healthcare system relationships, driving diagnostic adoption, and establishing health economic value rather than competing on price.
Brand ManagerMedical Science Liaison
Worked on XENOVIEW at Polarean Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.